APA

Van Gaal L. F., Caterson I. D., Coutinho W., Finer N., Maggioni A. P., Sharma A. M., Torp-Pedersen C., Ge H., Moran S. A., Shepherd G. M. & James W. P. T. (20110124). Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial. : Diabetes, obesity & metabolism.

Chicago

Van Gaal L F, Caterson I D, Coutinho W, Finer N, Maggioni A P, Sharma A M, Torp-Pedersen C, Ge H, Moran S A, Shepherd G M and James W P T. 20110124. Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial. : Diabetes, obesity & metabolism.

Harvard

Van Gaal L. F., Caterson I. D., Coutinho W., Finer N., Maggioni A. P., Sharma A. M., Torp-Pedersen C., Ge H., Moran S. A., Shepherd G. M. and James W. P. T. (20110124). Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial. : Diabetes, obesity & metabolism.

MLA

Van Gaal L F, Caterson I D, Coutinho W, Finer N, Maggioni A P, Sharma A M, Torp-Pedersen C, Ge H, Moran S A, Shepherd G M and James W P T. Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial. : Diabetes, obesity & metabolism. 20110124.